Global and Japan Influenza NA Inhibitor Market Insights, Forecast to 2027

Report ID: 1014770 | Published Date: Jan 2025 | No. of Page: 135 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Influenza NA Inhibitor Product Introduction
    1.2 Market by Type
        1.2.1 Global Influenza NA Inhibitor Market Size Growth Rate by Type
        1.2.2 Zanamivir
        1.2.3 Oseltamivir
        1.2.4 Peramivir
    1.3 Market by Application
        1.3.1 Global Influenza NA Inhibitor Market Size Growth Rate by Application
        1.3.2 Influenza A Treatment
        1.3.3 Influenza B Treatment
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Influenza NA Inhibitor Market Size, Estimates and Forecasts
        2.1.1 Global Influenza NA Inhibitor Revenue 2016-2027
        2.1.2 Global Influenza NA Inhibitor Sales 2016-2027
    2.2 Global Influenza NA Inhibitor, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Influenza NA Inhibitor Historical Market Size by Region (2016-2021)
        2.3.1 Global Influenza NA Inhibitor Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Influenza NA Inhibitor Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Influenza NA Inhibitor Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Influenza NA Inhibitor Sales Forecast by Region (2022-2027)
        2.4.2 Global Influenza NA Inhibitor Revenue Forecast by Region (2022-2027)

3 Global Influenza NA Inhibitor Competitor Landscape by Players
    3.1 Global Top Influenza NA Inhibitor Manufacturers by Sales
        3.1.1 Global Influenza NA Inhibitor Sales by Manufacturer (2016-2021)
        3.1.2 Global Influenza NA Inhibitor Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Influenza NA Inhibitor Manufacturers by Revenue
        3.2.1 Key Influenza NA Inhibitor Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Influenza NA Inhibitor Revenue by Manufacturers (2016-2021)
        3.2.3 Global Influenza NA Inhibitor Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Influenza NA Inhibitor Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Influenza NA Inhibitor Revenue in 2020
        3.2.6 Global Influenza NA Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Influenza NA Inhibitor Price by Manufacturers
    3.4 Global Influenza NA Inhibitor Manufacturing Base Distribution, Product Types
        3.4.1 Influenza NA Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Influenza NA Inhibitor Product Type
        3.4.3 Date of International Manufacturers Enter into Influenza NA Inhibitor Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Influenza NA Inhibitor Market Size by Type (2016-2021)
        4.1.1 Global Influenza NA Inhibitor Sales by Type (2016-2021)
        4.1.2 Global Influenza NA Inhibitor Revenue by Type (2016-2021)
        4.1.3 Influenza NA Inhibitor Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Influenza NA Inhibitor Market Size Forecast by Type (2022-2027)
        4.2.1 Global Influenza NA Inhibitor Sales Forecast by Type (2022-2027)
        4.2.2 Global Influenza NA Inhibitor Revenue Forecast by Type (2022-2027)
        4.2.3 Influenza NA Inhibitor Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Influenza NA Inhibitor Market Size by Application (2016-2021)
        5.1.1 Global Influenza NA Inhibitor Sales by Application (2016-2021)
        5.1.2 Global Influenza NA Inhibitor Revenue by Application (2016-2021)
        5.1.3 Influenza NA Inhibitor Price by Application (2016-2021)
    5.2 Influenza NA Inhibitor Market Size Forecast by Application (2022-2027)
        5.2.1 Global Influenza NA Inhibitor Sales Forecast by Application (2022-2027)
        5.2.2 Global Influenza NA Inhibitor Revenue Forecast by Application (2022-2027)
        5.2.3 Global Influenza NA Inhibitor Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
    6.1 Japan Influenza NA Inhibitor Market Size YoY Growth 2016-2027
        6.1.1 Japan Influenza NA Inhibitor Sales YoY Growth 2016-2027
        6.1.2 Japan Influenza NA Inhibitor Revenue YoY Growth 2016-2027
        6.1.3 Japan Influenza NA Inhibitor Market Share in Global Market 2016-2027
    6.2 Japan Influenza NA Inhibitor Market Size by Players (International and Local Players)
        6.2.1 Japan Top Influenza NA Inhibitor Players by Sales (2016-2021)
        6.2.2 Japan Top Influenza NA Inhibitor Players by Revenue (2016-2021)
    6.3 Japan Influenza NA Inhibitor Historic Market Review by Type (2016-2021)
        6.3.1 Japan Influenza NA Inhibitor Sales Market Share by Type (2016-2021)
        6.3.2 Japan Influenza NA Inhibitor Revenue Market Share by Type (2016-2021)
        6.3.3 Japan Influenza NA Inhibitor Price by Type (2016-2021)
    6.4 Japan Influenza NA Inhibitor Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 Japan Influenza NA Inhibitor Sales Forecast by Type (2022-2027)
        6.4.2 Japan Influenza NA Inhibitor Revenue Forecast by Type (2022-2027)
        6.4.3 Japan Influenza NA Inhibitor Price Forecast by Type (2022-2027)
    6.5 Japan Influenza NA Inhibitor Historic Market Review by Application (2016-2021)
        6.5.1 Japan Influenza NA Inhibitor Sales Market Share by Application (2016-2021)
        6.5.2 Japan Influenza NA Inhibitor Revenue Market Share by Application (2016-2021)
        6.5.3 Japan Influenza NA Inhibitor Price by Application (2016-2021)
    6.6 Japan Influenza NA Inhibitor Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 Japan Influenza NA Inhibitor Sales Forecast by Application (2022-2027)
        6.6.2 Japan Influenza NA Inhibitor Revenue Forecast by Application (2022-2027)
        6.6.3 Japan Influenza NA Inhibitor Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Influenza NA Inhibitor Market Size YoY Growth 2016-2027
    7.2 North America Influenza NA Inhibitor Market Facts & Figures by Country
        7.2.1 North America Influenza NA Inhibitor Sales by Country (2016-2021)
        7.2.2 North America Influenza NA Inhibitor Revenue by Country (2016-2021)
        7.2.3 U.S.
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Influenza NA Inhibitor Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Influenza NA Inhibitor Market Facts & Figures by Region
        8.2.1 Asia Pacific Influenza NA Inhibitor Sales by Region (2016-2021)
        8.2.2 Asia Pacific Influenza NA Inhibitor Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia
        8.2.12 Philippines
        8.2.13 Vietnam

9 Europe
    9.1 Europe Influenza NA Inhibitor Market Size YoY Growth 2016-2027
    9.2 Europe Influenza NA Inhibitor Market Facts & Figures by Country
        9.2.1 Europe Influenza NA Inhibitor Sales by Country (2016-2021)
        9.2.2 Europe Influenza NA Inhibitor Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Influenza NA Inhibitor Market Size YoY Growth 2016-2027
    10.2 Latin America Influenza NA Inhibitor Market Facts & Figures by Country
        10.2.1 Latin America Influenza NA Inhibitor Sales by Country (2016-2021)
        10.2.2 Latin America Influenza NA Inhibitor Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Influenza NA Inhibitor Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Influenza NA Inhibitor Market Facts & Figures by Country
        11.2.1 Middle East and Africa Influenza NA Inhibitor Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Influenza NA Inhibitor Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 Green Cross
        12.1.1 Green Cross Corporation Information
        12.1.2 Green Cross Description and Business Overview
        12.1.3 Green Cross Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Green Cross Influenza NA Inhibitor Products Offered
        12.1.5 Green Cross Recent Development
    12.2 Roche
        12.2.1 Roche Corporation Information
        12.2.2 Roche Description and Business Overview
        12.2.3 Roche Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Roche Influenza NA Inhibitor Products Offered
        12.2.5 Roche Recent Development
    12.3 GlaxoSmithKline
        12.3.1 GlaxoSmithKline Corporation Information
        12.3.2 GlaxoSmithKline Description and Business Overview
        12.3.3 GlaxoSmithKline Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 GlaxoSmithKline Influenza NA Inhibitor Products Offered
        12.3.5 GlaxoSmithKline Recent Development
    12.4 Henan DaKen Chemical
        12.4.1 Henan DaKen Chemical Corporation Information
        12.4.2 Henan DaKen Chemical Description and Business Overview
        12.4.3 Henan DaKen Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Henan DaKen Chemical Influenza NA Inhibitor Products Offered
        12.4.5 Henan DaKen Chemical Recent Development
    12.5 ATK Chemical
        12.5.1 ATK Chemical Corporation Information
        12.5.2 ATK Chemical Description and Business Overview
        12.5.3 ATK Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 ATK Chemical Influenza NA Inhibitor Products Offered
        12.5.5 ATK Chemical Recent Development
    12.6 Chemwill Asia Co.,Ltd.
        12.6.1 Chemwill Asia Co.,Ltd. Corporation Information
        12.6.2 Chemwill Asia Co.,Ltd. Description and Business Overview
        12.6.3 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Products Offered
        12.6.5 Chemwill Asia Co.,Ltd. Recent Development
    12.7 Shionogi Co.
        12.7.1 Shionogi Co. Corporation Information
        12.7.2 Shionogi Co. Description and Business Overview
        12.7.3 Shionogi Co. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Shionogi Co. Influenza NA Inhibitor Products Offered
        12.7.5 Shionogi Co. Recent Development
    12.8 NeoPharm
        12.8.1 NeoPharm Corporation Information
        12.8.2 NeoPharm Description and Business Overview
        12.8.3 NeoPharm Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 NeoPharm Influenza NA Inhibitor Products Offered
        12.8.5 NeoPharm Recent Development
    12.9 Moksha8 Pharma
        12.9.1 Moksha8 Pharma Corporation Information
        12.9.2 Moksha8 Pharma Description and Business Overview
        12.9.3 Moksha8 Pharma Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Moksha8 Pharma Influenza NA Inhibitor Products Offered
        12.9.5 Moksha8 Pharma Recent Development
    12.11 Green Cross
        12.11.1 Green Cross Corporation Information
        12.11.2 Green Cross Description and Business Overview
        12.11.3 Green Cross Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Green Cross Influenza NA Inhibitor Products Offered
        12.11.5 Green Cross Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Influenza NA Inhibitor Industry Trends
    13.2 Influenza NA Inhibitor Market Drivers
    13.3 Influenza NA Inhibitor Market Challenges
    13.4 Influenza NA Inhibitor Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Influenza NA Inhibitor Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Influenza NA Inhibitor Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Zanamivir
    Table 3. Major Manufacturers of Oseltamivir
    Table 4. Major Manufacturers of Peramivir
    Table 5. Global Influenza NA Inhibitor Market Size Growth Rate by Application (2021-2027) & (Kilotons)
    Table 6. Global Influenza NA Inhibitor Market Size by Region (Kilotons) & (US$ Million), 2016 VS 2021 VS 2027
    Table 7. Global Influenza NA Inhibitor Sales by Regions (2016-2021) & (Kilotons)
    Table 8. Global Influenza NA Inhibitor Sales Market Share by Regions (2016-2021)
    Table 9. Global Influenza NA Inhibitor Revenue by Regions (2016-2021) & (US$ Million)
    Table 10. Global Influenza NA Inhibitor Sales Forecast by Region (2022-2027) & (Kilotons)
    Table 11. Global Influenza NA Inhibitor Sales Market Share Forecast by Region (2022-2027)
    Table 12. Global Influenza NA Inhibitor Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 13. Global Influenza NA Inhibitor Revenue Market Share Forecast by Region (2022-2027)
    Table 14. Global Influenza NA Inhibitor Sales by Manufacturers (2016-2021) (Kilotons)
    Table 15. Global Influenza NA Inhibitor Sales Share by Manufacturers (2016-2021)
    Table 16. Ranking of Global Top Influenza NA Inhibitor Manufacturers by Revenue (US$ Million) in 2020
    Table 17. Influenza NA Inhibitor Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 18. Influenza NA Inhibitor Revenue Share by Manufacturers (2016-2021)
    Table 19. Global Influenza NA Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 20. Global Influenza NA Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza NA Inhibitor as of 2020)
    Table 21. Key Manufacturers Influenza NA Inhibitor Price (2016-2021) (US$/Kg)
    Table 22. Influenza NA Inhibitor Manufacturers Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Influenza NA Inhibitor Product Type
    Table 24. Date of International Manufacturers Enter into Influenza NA Inhibitor Market
    Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 26. Global Influenza NA Inhibitor Sales by Type (2016-2021) (Kilotons)
    Table 27. Global Influenza NA Inhibitor Sales Share by Type (2016-2021)
    Table 28. Global Influenza NA Inhibitor Revenue by Type (2016-2021) (US$ Million)
    Table 29. Global Influenza NA Inhibitor Revenue Share by Type (2016-2021)
    Table 30. Influenza NA Inhibitor Average Selling Price (ASP) by Type (2016-2021) & (US$/Kg)
    Table 31. Global Influenza NA Inhibitor Sales Forecast by Type (2022-2027) & (Kilotons)
    Table 32. Global Influenza NA Inhibitor Sales Market Share Forecast by Type (2022-2027)
    Table 33. Global Influenza NA Inhibitor Revenue Forecast V (2022-2027) & (US$ Million)
    Table 34. Global Influenza NA Inhibitor Revenue Market Share Forecast by Type (2022-2027)
    Table 35. Global Influenza NA Inhibitor Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Kg)
    Table 36. Global Influenza NA Inhibitor Sales by Application (2016-2021) (Kilotons)
    Table 37. Global Influenza NA Inhibitor Sales Share by Application (2016-2021)
    Table 38. Global Influenza NA Inhibitor Revenue by Application (2016-2021) (US$ Million)
    Table 39. Global Influenza NA Inhibitor Revenue Share by Application (2016-2021)
    Table 40. Influenza NA Inhibitor Average Selling Price (ASP) by Application (2016-2021) & (US$/Kg)
    Table 41. Global Influenza NA Inhibitor Sales Forecast by Application (2022-2027) & (Kilotons)
    Table 42. Global Influenza NA Inhibitor Sales Market Share Forecast by Application (2022-2027)
    Table 43. Global Influenza NA Inhibitor Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 44. Global Influenza NA Inhibitor Revenue Market Share Forecast by Application (2022-2027)
    Table 45. Global Influenza NA Inhibitor Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Kg)
    Table 46. Japan Influenza NA Inhibitor Sales (Kilotons) of Key Companies (2016-2021)
    Table 47. Japan Influenza NA Inhibitor Sales Share by Company (2016-2021)
    Table 48. Japan Influenza NA Inhibitor Revenue (US$ Million) by Company (2016-2021)
    Table 49. Japan Influenza NA Inhibitor Revenue Share by Company (2016-2021)
    Table 50. Japan Influenza NA Inhibitor Sales (Kilotons) by Type (2016-2021)
    Table 51. Japan Influenza NA Inhibitor Sales Share by Type (2016-2021)
    Table 52. Japan Influenza NA Inhibitor Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 53. Japan Influenza NA Inhibitor Price (US$/Kg) by Type (2016-2021)
    Table 54. Japan Influenza NA Inhibitor Sales (Kilotons) by Type (2022-2027)
    Table 55. Japan Influenza NA Inhibitor Sales Share by Type (2022-2027)
    Table 56. Japan Influenza NA Inhibitor Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 57. Japan Influenza NA Inhibitor Revenue Share by Type (2022-2027)
    Table 58. Japan Influenza NA Inhibitor Price (US$/Kg) by Type (2022-2027)
    Table 59. Japan Influenza NA Inhibitor Sales (Kilotons) by Application (2016-2021)
    Table 60. Japan Influenza NA Inhibitor Sales Share by Application (2016-2021)
    Table 61. Japan Influenza NA Inhibitor Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 62. Japan Influenza NA Inhibitor Price (US$/Kg) by Application (2016-2021)
    Table 63. Japan Influenza NA Inhibitor Sales (Kilotons) by Application (2022-2027)
    Table 64. Japan Influenza NA Inhibitor Sales Share by Application (2022-2027)
    Table 65. Japan Influenza NA Inhibitor Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 66. Japan Influenza NA Inhibitor Revenue Share by Application (2022-2027)
    Table 67. Japan Influenza NA Inhibitor Price (US$/Kg) by Application (2022-2027)
    Table 68. North America Influenza NA Inhibitor Sales by Country (2016-2021) & (Kilotons)
    Table 69. North America Influenza NA Inhibitor Sales Market Share by Country (2016-2021)
    Table 70. North America Influenza NA Inhibitor Revenue by Country (2016-2021) & (US$ Million)
    Table 71. North America Influenza NA Inhibitor Revenue Market Share by Country (2016-2021)
    Table 72. Asia Pacific Influenza NA Inhibitor Sales by Region (2016-2021) & (Kilotons)
    Table 73. Asia Pacific Influenza NA Inhibitor Sales Market Share by Region (2016-2021)
    Table 74. Asia Pacific Influenza NA Inhibitor Revenue by Region (2016-2021) & (US$ Million)
    Table 75. Asia Pacific Influenza NA Inhibitor Revenue Market Share by Region (2016-2021)
    Table 76. Europe Influenza NA Inhibitor Sales by Country (2016-2021) & (Kilotons)
    Table 77. Europe Influenza NA Inhibitor Sales Market Share by Country (2016-2021)
    Table 78. Europe Influenza NA Inhibitor Revenue by Country (2016-2021) & (US$ Million)
    Table 79. Europe Influenza NA Inhibitor Revenue Market Share by Country (2016-2021)
    Table 80. Latin America Influenza NA Inhibitor Sales by Country (2016-2021) & (Kilotons)
    Table 81. Latin America Influenza NA Inhibitor Sales Market Share by Country (2016-2021)
    Table 82. Latin Americaa Influenza NA Inhibitor Revenue by Country (2016-2021) & (US$ Million)
    Table 83. Latin America Influenza NA Inhibitor Revenue Market Share by Country (2016-2021)
    Table 84. Middle East and Africa Influenza NA Inhibitor Sales by Country (2016-2021) & (Kilotons)
    Table 85. Middle East and Africa Influenza NA Inhibitor Sales Market Share by Country (2016-2021)
    Table 86. Middle East and Africa Influenza NA Inhibitor Revenue by Country (2016-2021) & (US$ Million)
    Table 87. Middle East and Africa Influenza NA Inhibitor Revenue Market Share by Country (2016-2021)
    Table 88. Green Cross Corporation Information
    Table 89. Green Cross Description and Business Overview
    Table 90. Green Cross Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 91. Green Cross Influenza NA Inhibitor Product
    Table 92. Green Cross Recent Development
    Table 93. Roche Corporation Information
    Table 94. Roche Description and Business Overview
    Table 95. Roche Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 96. Roche Product
    Table 97. Roche Recent Development
    Table 98. GlaxoSmithKline Corporation Information
    Table 99. GlaxoSmithKline Description and Business Overview
    Table 100. GlaxoSmithKline Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 101. GlaxoSmithKline Product
    Table 102. GlaxoSmithKline Recent Development
    Table 103. Henan DaKen Chemical Corporation Information
    Table 104. Henan DaKen Chemical Description and Business Overview
    Table 105. Henan DaKen Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 106. Henan DaKen Chemical Product
    Table 107. Henan DaKen Chemical Recent Development
    Table 108. ATK Chemical Corporation Information
    Table 109. ATK Chemical Description and Business Overview
    Table 110. ATK Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 111. ATK Chemical Product
    Table 112. ATK Chemical Recent Development
    Table 113. Chemwill Asia Co.,Ltd. Corporation Information
    Table 114. Chemwill Asia Co.,Ltd. Description and Business Overview
    Table 115. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 116. Chemwill Asia Co.,Ltd. Product
    Table 117. Chemwill Asia Co.,Ltd. Recent Development
    Table 118. Shionogi Co. Corporation Information
    Table 119. Shionogi Co. Description and Business Overview
    Table 120. Shionogi Co. Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 121. Shionogi Co. Product
    Table 122. Shionogi Co. Recent Development
    Table 123. NeoPharm Corporation Information
    Table 124. NeoPharm Description and Business Overview
    Table 125. NeoPharm Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 126. NeoPharm Product
    Table 127. NeoPharm Recent Development
    Table 128. Moksha8 Pharma Corporation Information
    Table 129. Moksha8 Pharma Description and Business Overview
    Table 130. Moksha8 Pharma Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 131. Moksha8 Pharma Product
    Table 132. Moksha8 Pharma Recent Development
    Table 133. Influenza NA Inhibitor Market Trends
    Table 134. Influenza NA Inhibitor Market Drivers
    Table 135. Influenza NA Inhibitor Market Challenges
    Table 136. Influenza NA Inhibitor Market Restraints
    Table 137. Influenza NA Inhibitor Customers List
    Table 138. Influenza NA Inhibitor Distributors List
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Influenza NA Inhibitor Product Picture
    Figure 2. Global Influenza NA Inhibitor Sales Market Share by Type in 2020 & 2027
    Figure 3. Zanamivir Product Picture
    Figure 4. Oseltamivir Product Picture
    Figure 5. Peramivir Product Picture
    Figure 6. Global Influenza NA Inhibitor Sales Market Share by Application in 2020 & 2027
    Figure 7. Influenza A Treatment
    Figure 8. Influenza B Treatment
    Figure 9. Influenza NA Inhibitor Report Years Considered
    Figure 10. Global Influenza NA Inhibitor Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Influenza NA Inhibitor Market Size 2016-2027 (US$ Million)
    Figure 12. Global Influenza NA Inhibitor Sales 2016-2027 (Kilotons)
    Figure 13. Global Influenza NA Inhibitor Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Influenza NA Inhibitor Sales Market Share by Region (2016-2021)
    Figure 15. Global Influenza NA Inhibitor Sales Market Share by Region in 2020
    Figure 16. Global Influenza NA Inhibitor Revenue Market Share by Region (2016-2021)
    Figure 17. Global Influenza NA Inhibitor Revenue Market Share by Region in 2020
    Figure 18. Global Influenza NA Inhibitor Sales Share by Manufacturer in 2020
    Figure 19. The Top 10 and 5 Players Market Share by Influenza NA Inhibitor Revenue in 2020
    Figure 20. Influenza NA Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 21. Global Influenza NA Inhibitor Sales Market Share by Type (2016-2021)
    Figure 22. Global Influenza NA Inhibitor Sales Market Share by Type in 2020
    Figure 23. Global Influenza NA Inhibitor Revenue Market Share by Type (2016-2021)
    Figure 24. Global Influenza NA Inhibitor Revenue Market Share by Type in 2020
    Figure 25. Global Influenza NA Inhibitor Sales Market Share by Application (2016-2021)
    Figure 26. Global Influenza NA Inhibitor Sales Market Share by Application in 2020
    Figure 27. Global Influenza NA Inhibitor Revenue Market Share by Application (2016-2021)
    Figure 28. Global Influenza NA Inhibitor Revenue Market Share by Application in 2020
    Figure 29. Japan Influenza NA Inhibitor Sales Growth Rate 2016-2027 (Kilotons)
    Figure 30. Japan Influenza NA Inhibitor Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 31. Japan Influenza NA Inhibitor Market Share in Global Market 2016-2027
    Figure 32. Japan 5 and 10 Largest Influenza NA Inhibitor Players Market Share by Revenue in Influenza NA Inhibitor in 2020
    Figure 33. Japan Influenza NA Inhibitor Revenue Share by Type (2016-2021)
    Figure 34. Japan Influenza NA Inhibitor Revenue Growth Rate by Type in 2016 & 2020
    Figure 35. Japan Influenza NA Inhibitor Revenue Share by Application (2016-2021)
    Figure 36. Japan Influenza NA Inhibitor Revenue Growth Rate by Application in 2016 & 2020
    Figure 37. North America Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
    Figure 38. North America Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 39. North America Influenza NA Inhibitor Sales Market Share by Country in 2020
    Figure 40. North America Influenza NA Inhibitor Revenue Market Share by Country in 2020
    Figure 41. U.S. Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 42. U.S. Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Canada Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 44. Canada Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Europe Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
    Figure 46. Europe Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 47. Europe Influenza NA Inhibitor Sales Market Share by Country in 2020
    Figure 48. Europe Influenza NA Inhibitor Revenue Market Share by Country in 2020
    Figure 49. Germany Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 50. Germany Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 51. France Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 52. France Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. U.K. Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 54. U.K. Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. Italy Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 56. Italy Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Russia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 58. Russia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Asia Pacific Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
    Figure 60. Asia Pacific Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 61. Asia Pacific Influenza NA Inhibitor Sales Market Share by Region in 2020
    Figure 62. Asia Pacific Influenza NA Inhibitor Revenue Market Share by Region in 2020
    Figure 63. China Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 64. China Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 65. Japan Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 66. Japan Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. South Korea Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 68. South Korea Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. India Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 70. India Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. Australia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 72. Australia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Taiwan Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 74. Taiwan Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Indonesia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 76. Indonesia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Thailand Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 78. Thailand Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Malaysia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 80. Malaysia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Philippines Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 82. Philippines Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Vietnam Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 84. Vietnam Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 85. Latin America Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
    Figure 86. Latin America Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 87. Latin America Influenza NA Inhibitor Sales Market Share by Country in 2020
    Figure 88. Latin America Influenza NA Inhibitor Revenue Market Share by Country in 2020
    Figure 89. Mexico Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 90. Mexico Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Brazil Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 92. Brazil Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Argentina Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 94. Argentina Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 95. Middle East and Africa Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
    Figure 96. Middle East and Africa Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 97. Middle East and Africa Influenza NA Inhibitor Sales Market Share by Country in 2020
    Figure 98. Middle East and Africa Influenza NA Inhibitor Revenue Market Share by Country in 2020
    Figure 99. Turkey Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 100. Turkey Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. Saudi Arabia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 102. Saudi Arabia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. UAE Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
    Figure 104. UAE Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 105. Influenza NA Inhibitor Value Chain
    Figure 106. Channels of Distribution
    Figure 107. Distributors Profiles
    Figure 108. Bottom-up and Top-down Approaches for This Report
    Figure 109. Data Triangulation
    Figure 110. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Green Cross
Roche
GlaxoSmithKline
Henan DaKen Chemical
ATK Chemical
Chemwill Asia Co.,Ltd.
Shionogi Co.
NeoPharm
Moksha8 Pharma
Frequently Asked Questions
Influenza NA Inhibitor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Influenza NA Inhibitor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Influenza NA Inhibitor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sugar-Free Soda

Sugar-Free Soda market is segmented by region (country), players, by Type, and by Application. Pl ... Read More